Specialized capabilities increase our reach

In addition to our broad portfolio of synthesis technologies, Archimica has developed a range of special capabilities that provide additional levels of value or that create opportunities for outsourcing based on our facilities.

	Sterile API's New options for more complex molecules Archimica is a leading provider of bulk sterile APIs for the pharmaceutical market, offering state-of-the-art technology, broad synthesis capability and a full range of developmental and manufacturing options to meet the specialized needs of a sterile drug commercialization project.
	Controlled substance manufacturing Excellence in a highly regulated environment Archimica manufactures drugs at its Springfield, Missouri USA facility that are considered ‘controlled substances’ by the United States Drug Enforcement Agency.